Swissinfo – Novartis Patent Case – Indacaterol – Onbrez Delhi High Court Judgement
April 25th, 2019
Swissinfo is Swiss Government’s International Publication Service managed by Swiss Broadcasting Corporation (SBC).Views on Delhi High Court’s ruling in Novartis patent dispute:
“the ruling is totally in line with existing laws, rules and judicial precedents. For example, the Indian patents act provides provisions for revocation of patent rights in case such rights are against public interest”.
Full article can be seen here: Is the tide against Big Pharma in India turning?
Onbrez (Indacaterol) is an ultra-long-acting beta-adrenoceptor agonist developed by Novartis, which was approved by the European Medicines Agency (EMA) under the trade name Onbrez Breezhaler, and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler.
Novartis has filed five (5) patents in India for protecting Onbrez
(i) IN222346 titled “BETA 2-ADRENOCEPTOR AGONISTS”
(ii) IN214320 titled “A PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFLAMMATORY AND OBSTRUCTIVE AIRWAYS DISEASES”
(iii) IN230049 titled “A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES”
(iv) IN210047 titled “PROCESS FOR PREPARING 2-AMINOINDAN DERIVATIVES”
(iv) IN230312 titled “A PROCESS FOR PREPARING 5-[(R)-2-(5,6-DIETHYL-INDAN-2-YLAMINO)-1-HYDROXY-ETHYL]-8-HYDROXY-(1H)-QUINOLIN-2-ONE SALTS”
In January 2015, Delhi High Court barred Cipla from making or selling a cheaper copy of Onbrez, citing infringement of patents held by Novartis.
Rahul Dev, Partner at the law firm of Tech Corp Legal LLP, is a patent attorney and international technology business lawyer. Dev’s corporate law practice is aimed at integrating patents, technology laws, intellectual property rights, regulatory and security laws to provide services to FinTech companies.
Patent Drafting Resources
Patent Drafting and Writing Strong Patent Applications for Creating & Protecting Inventions
Patent Application Writing Guide | Ultimate Cheat Sheet for Drafting Software Patents and Mobile App Patents
Patents in MedTech – Online Healthcare & Medical Practice Management
Patent Research & Analytics | Where Patent Analytics Are Headed – Harnessing Power of Patent Analytics for Patent Strategy
Frequently asked questions (FAQs) | Drafting and Writing Provisional & Non-Provisional Patent Applications (Specifications)
How and Why are Patents Important for Technology Companies & Startups In Asia?
How can Patent Search help in determining Patentability of Invention?
What is the meaning of Patent Pending Status?
What are advantages of Filing a Provisional Patent Application?
What is a Provisional Patent Application?
About Us – Indian Patent Law Firm
We, at Tech Corp Legal LLP, an Indian law firm serving global clients and patent attorneys worldwide, provide quality patent drafting services to inventors. Along with patent support services provided by GIP Research, we offer top quality patent specification drafting services including enforceable patent claims and high quality patent illustrations.
Our team of patent attorneys and technical patent experts has comprehensive experience in executing projects pertaining to international patent drafting, patent drafting services, drafting patent claims and patent applications, software and mobile app patents, provisional and non-provisional patents, patent searches, office action responses, etc.
Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology & Corporate Laws. He is reachable at info (at) techcorplegal (dot) com & @rdpatentlawyer on Twitter
Discuss your Queries
https://clarity.fm/assets/widget_loader.jsFrequently asked questions – Patents, Technology & Internet Laws ***************************************
To get in touch with us, please click here.
View our presentations here.
About the Author: Rahul Dev
Engagements: Contractual Consulting, Hourly, Project Based
Contact Mode: LinkedIn or directly message here